Tekmira Pharmaceuticals’ (TKMR) Treatment Used in First American Ebola Cases
October 06, 2014 at 09:36 AM EDT
Shares of Tekmira Pharmaceuticals Corp. (TKMR) were down -1.86 or -6.30 percent to $27.67 per share in premarket trading this morning. The stock is trading correctively after the shares surged on Friday as news that medical facilities will be using its TKM-Ebola treatment on the first U.S. Ebola cases. Tekmira Pharmaceuticals stock closed at $29.53 Read the full article... Read the rest of Tekmira Pharmaceuticals’ (TKMR) Treatment Used in First American Ebola Cases at InvestorGuide.com .
